Spectra of antinuclear antibodies in patients with squamous cell carcinoma of the lung and of the head and neck

Cancer Detection and Prevention

Volumn 29, Issue 1, 2005, Pages 59-65

  Madrid, Félix Fernández ^a,b   Karvonen, Robert L ^c   Ensley, John ^a   Kraut, Michael ^a   Granda, José L ^a   Alansari, Huda ^a   Tang, Naimei ^a   Tomkiel, John E ^a,d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c Science Institute   (United States)

^d UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

Antinuclear antibodies; Autoimmunity; Head and neck cancer; Keratinocytes; Lung cancer; Serologic markers

Indexed keywords

ANTINUCLEAR ANTIBODY; CELL NUCLEUS ANTIGEN;

ARTICLE; AUTOIMMUNITY; CELL CULTURE; CELL TYPE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; KERATINOCYTE; LUNG CANCER; LUNG FIBROBLAST; LUNG SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROSCOPY;

EID: 14144256502     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2004.10.002     Document Type: Article

References (51)

1. C.H. Scoggin Pulmonary neoplasms J.B. Wyngaarten L.H. Smith J.C. Bennett Cecil, Textbook of medicine 19th ed. 1992 WB Saunders 435 443
2. W.A. Fry, H.R. Menck, and D.P. Winchester The national cancer data base report on lung cancer Cancer 77 1999 1947 1955
3. L.A.G. Reis, C.L. Kosary, and B.F. Hankey SEER cancer statistics review 1999 National Cancer Institute Bethesda, MD
4. W.B. Coleman, and G.J. Tsongalis Cancer epidemiology W.B. Coleman G.J. Tsongalis The molecular basis of human cancer 2002 Humana Press Totowa, N J 3 22
5. R. Sankaranarayanan, E. Masuyer, and R. Swaminathan Head and neck cancer: a global perspective on epidemiology and prognosis Anticancer Res 18 1998 4779 4786
6. A. Forastiere, W. Koch, A. Trotti, and D. Sidransky Medical progress: head and neck cancer N Engl J Med 345 2001 1890 1900
7. P.P. Leong, B. Rezai, and W.M. Koch Distiguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma J. Natl Cancer Inst 90 1998 972 977
8. I.J. Dhooge, M. DeVos, and P.B. Van Cauwenberge Multiple primary malignant tumors in patients with head and neck cancer: results of a prospective study and future perpectives Laryngoscope 108 1998 250 256
9. A. Narayana, A.T. Vaughan, and S.G. Fisher Second primary tumors in laryngeal cancer: results of long-term follow up Int J Radiat Oncol, Biol, Phys 42 1998 557 562
10. R.S. Fontana, D.R. Sanderson, and L.B. Woolner Screening for lung cancer: a critique of the Mayo lung project Cancer 67 1991 1155 1164
11. R.L. Manser, L.B. Irving, and G. Byrnes Screening for lung cancer: a systematic review and meta-analysis of controlled trials Thorax 58 2003 784 789
12. F.M. Brichori, D.E. Misek, and A.M. Yim An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer Proc Natl Acad Sci U S A 98 2001 9824 9829
13. J. Niklinski, L. Chyczewski, and H.D. Becker Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications Eur J Cancer Prev 10 2001 213 226
14. J.L. Mulshine Reducing lung cancer risk. Early detection Chest 116 1999 493S 496S
15. J.T. Wadsworth, K. Sommers, and B. Stack Identification of patients with head and neck cancer using serum protein profiles Arch Otolaryngol-Head Neck Surg 130 2004 98 104
16. G.I. Selvaggi, S. Novello, and V. Torri Epidermal growth factor receptor overexpression correlates with poor prognosis in completely resected stage I-IIIA non-small lung cancer Ann Oncol 15 2004 28 32
17. J. Brown, H. Xu, and J. Nishitani Potential biomarkers for head and neck squamous cell carcinoma Laryngoscope 113 2003 393 400
18. I. Wong, Y. Lo, and P. Johnson Epigenetic tumor markers in plasma and serum: biology and applications to molecular diagnosis and disease monitoring Ann N Y Acad Sci 945 2001 36 50
19. H.E. Gonzalez, M. Gujratio, and M. Frederick Identification of 9 genes differentially expressed in head and neck squamous cell carcinoma Arch Otolaryngol 129 2003 754 759
20. M. Verma, B.K. Dunn, and S. Ross Early detection and risk assessment proceedings and recommendations from the workshop on epigenetics in cancer prevention Ann N Y Acad Sci 983 2003 298 319
21. W. Koch Genetic markers in the clinical care of head and neck cancer: slow in coming Arch Otolaryngol-Head Neck Cancer 129 2001 367 368
22. J.J. Brown, H. Xu, and J. Nishitani Potential biomarkers for head and neck squamous cell carcinoma Laryngoscope 113 2003 393 400
23. F. Fernández Madrid, J.L. Granda, and P. VandeVord Antinuclear antibodies in lung cancer Cancer Detect Prev 22 1998 S185
24. F. Fernández Madrid, P.J. VandeVord, and X. Yang Antinuclear antibodies as potential markers of lung cancer Clin Cancer Res 5 1999 1393 1400
25. F. Fernández Madrid, and J.E. Tomkiel Antinuclear antibodies as potential markers in the diagnosis and prognosis of lung cancer Y. Shoenfeld M.E. Gershwin Cancer and autoimmunity 2000 Elsevier Science 151 158
26. U.K. Laemli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature (London) 227 1970 680 685
27. H. Towbin, T. Stahelin, and J. Gordon Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications Proc Natl Acad Sci U S A 76 1979 4350 4354
28. L. Breiman, J.H. Friedman, and R.A. Olshen Classification and regression trees 1984 Wadsworth Belmont, CA
29. L.A. Clack, and D. Pregibon Tree-based models J.M. Chambers TJ. Haste Statistical models 1992 Wadsworth S. Pacific grove, CA
30. D. Steinberg, and C. Phillip CART: tree structured nonparametric data analysis 1995 Salford Systems San Diego, CA
31. E. Rubin, and J.L. Farber The respiratory system E. Rubin J.L. Farber Pathology 1994 JB Lippincott Co. Philadelphia 557 617
32. S.S. Hecht Tobacco smoke carcinogens and lung cancer J Natl Cancer Inst 91 1999 1194 1210
33. P. Zamboni, R. Talamini, and C. La Vecchia Smoking, type of alcoholic beverage and squamous-cell oesophageal cancer in northen Italy Int J Cancer 86 2000 144 149
34. M.E. Hodson, and M. Turner-Warwick Autoantibodies in patients with bronchial carcinoma Thorax 30 1975 367 370
35. S.E. Kornguth, R. Klein, R. Appen, and J. Choate Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung Cancer 50 1982 1289 1293
36. C. Buddle-Steffen, N.E. Anderson, and M.K. Rosenblum Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionopathy Cancer Res 48 1988 430 434
37. S.F. Winter, J.D. Minna, B.E. Johnson, T. Takahashi, A.F. Gazdar, and D.P. Carbone Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation Cancer Res 52 1992 4168 4174
38. J. Dalmau, F. Graus, and M.K. Rosenblum Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuropathy. A clinical study of 71 patients Medicine 71 1992 59 72
39. K. Frenkel, J. Karkoszka, and J. Kato Systemic biomarkers of cancer risk Cancer Detect Prev 20 1996 234
40. L.A. Mooney, F.P. Perera, and A.M. Van Bennekum Gender differences in autoantibodies to oxidative DNA base damage in cigarette smokers Cancer Epidemiol Biomarkers Prev 10 2001 641 648
41. G.J. Anhalt, and H.C. Nousari Paraneoplastic autoimmune syndromes N.R. Rose I.R. Mackay The autoimmune diseases 3rd ed. 1998 Academic Press 775 778
42. S. Sangrajrang, A. Sornprom, and G. Chernrungroj Serum p53 antibodies in patients with lung cancer: correlation with clinicopathologic features and smoking Lung Cancer 39 2003 297 301
43. H.W. Jones Jr., and V.A. McKusick George Otto Gey (1899-1970). The He La cell and a reappraisal of its origin Obstet Gynecol 38 1971 945 949
44. A.F. Olshan, M.C. Weissler, and H. Pei P53 mutational spectra in head and neck cancer: new data and evaluation of mutational spectra Cancer Epidemiol Biomarkers Prev 6 1997 499 504
45. Jo. Boyle, J. Hakim, and W. Koch The incidence of p53 mutations increases with progression of head and neck cancer Cancer Res 53 1993 4477 4488
46. N. Hu, M.J. Roth, and M.R. Emmert-Buck Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer Clin Cancer Res 5 1999 3476 3482
47. P.G. Shields Molecular epidemiology of lung cancer Ann Oncol 5 1999 S7 S11
48. I. Wistuba, C. Beherens, and S. Milchgrub Sequential abnormalities are involved in the multistage development of squamous cell lung carcinoma Oncogene 18 1999 643 650
49. W.A. Franklin, A.F. Gazdar, and J. Haney Widely dispersed p53 mutation in respiratory epithelium: a novel mechanism for field carcinogenesis J Clin Invest 100 1997 2133 2137
50. J.E. Tomkiel, H. Alansari, and N. Tang Autoimmunity to the Mr 32,000 subunit of replication protein a in breast cancer Clin Cancer Res 8 2002 752 758
51. F. Fernández Madrid, N. Tang, and H. Alansari Autoantibodies to annexin XI and other autoantigens in the diagnosis of breast cancer Cancer Res 64 2004 5089 5096